Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
martedì, novembre 17
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Turn Therapeutics Inc
TTRX
NASDAQ
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$8.55
N/A
In chiusura: Nov 17, 4:00 PM EST
$8.55
N/A
Post-mercato: Nov 16, 4:00 PM EST
Get Report
Panoramica
Notizie
Grafici
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Turn Therapeutics Financials
Turn Therapeutics (TTRX) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Turn Therapeutics Q3 EPS $(0.21) Misses $(0.09) Estimate
Turn Therapeutics (NASDAQ:TTRX) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.09) by 162.5 percent. This is a 200 percent decrease over losses of $(0.07) per share
Benzinga Newsdesk
PRO
Turn Therapeutics Q2 EPS $(0.20) Misses $(0.02) Estimate
Benzinga Newsdesk
PRO
Turn Therapeutics Q1 EPS $(0.03) Misses $(0.02) Estimate
Turn Therapeutics (NASDAQ:TTRX) reported quarterly losses of $(0.03) per share which missed the analyst consensus estimate of $(0.02) by 50 percent. This is a 200 percent decrease over losses of $(0.01) per share from
Benzinga Newsdesk
PRO
Turn Therapeutics Q4 EPS $0.01
Turn Therapeutics (NASDAQ:TTRX) reported quarterly earnings of $0.01 per share.
Benzinga Newsdesk
PRO
Turn Therapeutics Q3 EPS $(0.07) vs $(0.03) Prior
Benzinga Newsdesk
Dow Dips Over 250 Points; Delta Air Lines Posts Upbeat Earnings
Avi Kapoor